Skip to main
ISRG

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical (ISRG) Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 38%
Buy 44%
Hold 13%
Sell 0%
Strong Sell 6%

Bulls say

Intuitive Surgical demonstrates robust growth in procedure volumes, particularly in the US, with a notable 90 basis point increase in year-over-year procedure growth, largely attributed to advancements in General Surgery. The installation of both Ion and SP systems reflects strong demand, with Ion utilization growing by 11% and SP utilization increasing by 21%, indicative of the company's expanding market presence and customer adoption. The upward trend in average selling prices (ASPs) for systems further underscores Intuitive Surgical's financial strength and positions the company favorably in a recovering surgical market.

Bears say

The analysis indicates that Intuitive Surgical is facing pressures on average selling prices (ASPs) for both systems and instrumentation and accessories (I&A), primarily driven by a decline in bariatric procedures and shifts in procedural trends. Despite the launch of the da Vinci System 5 (Dv5), which accounts for all system sales growth, the contribution of the Dv5 to I&A revenue growth appears limited, suggesting underlying issues in procedural growth that impact the entire business model. Additionally, the slower-than-expected growth in the Japanese market, alongside risks from increased competition and challenges in the capital purchasing environment, further compounds concerns regarding the company's future performance.

Intuitive Surgical (ISRG) has been analyzed by 16 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 44% recommend Buy, 13% suggest Holding, 0% advise Selling, and 6% predict a Strong Sell.

This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Intuitive Surgical (ISRG) Forecast

Analysts have given Intuitive Surgical (ISRG) a Buy based on their latest research and market trends.

According to 16 analysts, Intuitive Surgical (ISRG) has a Buy consensus rating as of Apr 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $611.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $611.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Intuitive Surgical (ISRG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.